Cure My Disease

Don't miss your cure!

 Log in / Sign up

New MRI-like method tracks fat from plate to bloodstream

NCT ID NCT04156503

Knowledge-focused Sponsor: Malaysia Palm Oil Board Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to measure fats in the blood after a meal using a technique called NMR spectroscopy. 14 healthy adults ate a test meal, and researchers collected blood samples to see how different fat types were absorbed. The goal was to improve methods for studying fat digestion, not to treat any disease.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

14 people

The number who actually took part.

Started

Oct 2019

Finished

Dec 2020

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 40 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Non muslim, aged between 25 - 40 yrs old. * BMI between 20 - 27.5 kg/m2. * Blood pressure with \<130mmHg for systolic pressure and \< 80 mmHg for diastolic pressure. * Blood glucose level in the range of 3.9 to 5.5 mmol/L. * Total cholesterol level \< 6.0 mmol/L. * Triglycerides level \< 2.3 mmol/L. * No use of tobacco and no consumption of alcohol. Exclusion Criteria: * Suffer from chronic disease such as CVD, hypertension, diabetic, metabolic syndrome. * Consuming any medical prescriptions/ supplements. * Having blood clotting problem. * Women who are pregnant or lactating. * Hypertensive condition with systolic pressure \>140mmHg and diastolic pressure \> 90 mmHg.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Healthy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Healthy

Contacts and locations

Locations

  • MalaysiaPOB

    Kajang, Selangor, 43000, Malaysia

More trials for these conditions

Other studies related to the condition(s) this trial covers.